StocktoriaCollPlant Biotechnologies Ltd CLGN
Nasdaq · XNAS · stock · Orthopedic, Prosthetic & Surgical Appliances & Supplies
Chart by TradingView
3/9
Piotroski F — financial health
-41.05
Altman Z″ — distress risk · distress
—
Dividend payout · no dividend
Financials & ratios (annual, from 10-K)
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Financials | |||||
| Revenue | $2.4M | $515,000 | $11.0M | $299,000 | $15.6M |
| Gross profit | $1.5M | -$1.1M | $9.0M | -$101,000 | $13.6M |
| Operating income | -$11.5M | -$17.3M | -$7.5M | -$17.1M | $65,000 |
| Net income | -$11.5M | -$16.6M | -$7.0M | -$16.9M | $237,000 |
| Operating cash flow | -$9.4M | -$14.1M | -$2.8M | -$13.7M | $2.5M |
| Free cash flow | -$9.4M | -$14.6M | -$3.7M | -$15.0M | $1.1M |
| Total assets | $10.8M | $18.7M | $34.1M | $37.8M | $51.2M |
| Total liabilities | $4.7M | $5.2M | $5.8M | $5.5M | $6.1M |
| Shareholders' equity | $6.1M | $13.5M | $28.3M | $32.3M | $45.1M |
| Ratios | |||||
| Gross margin | 64.8% | -215.5% | 81.8% | -33.8% | 87.2% |
| Operating margin | -484.3% | -3349.7% | -68.5% | -5718.1% | 0.4% |
| Net margin | -484.6% | -3225.0% | -64.0% | -5660.5% | 1.5% |
| FCF margin | -398.4% | -2830.3% | -33.9% | -5007.4% | 6.9% |
| Return on assets | -106.5% | -88.8% | -20.6% | -44.8% | 0.5% |
| Return on equity | -188.9% | -123.3% | -24.8% | -52.4% | 0.5% |
| Debt / equity | — | — | — | — | 0.00× |
| Current ratio | 2.53 | 4.44 | 8.62 | 10.20 | 14.96 |
| Revenue growth | 360.4% | -95.3% | 3565.2% | -98.1% | 154.9% |
Why these scores methodology →
Piotroski F-score: 3/9
- Positive return on assets
- Positive operating cash flow
- Rising ROA
- Cash flow exceeds net income
- Lower long-term debt
- Rising current ratio
- No share dilution
- Rising gross margin
- Rising asset turnover
Altman Z″: -41.05 (distress)
- Working capital / assets 0.378
- Retained earnings / assets -11.575
- EBIT / assets -1.065
- Equity / liabilities 1.293
Sector peers
VFS · TM · HMC · SONY · AAPL · XOM · all Manufacturing →
Source: SEC EDGAR filings · CIK 0001631487 · as of 2025-12-31. Figures are facts from filings plus Stocktoria's own computed scores — not investment advice.